Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Opicapone in Parkinson's Disease Add -on to Levodopa Carbidopa Intestinal Gel

NCT06432309 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.

NCT NCT06432309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06432309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Opicapone in Parkinson's Disease Add -on to Levodopa Carbidopa Intestinal Gel
Lead sponsor
University Hospital of Ferrara
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2022
Completion date
April 25, 2024
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, parkinson disease